Boston Scientific's Acuity lead approved by FDA

04/17/2007 | Bloomberg Businessweek

The Acuity steerable left ventricular lead can be inserted into the heart via blood vessels and is used with cardiac resynchronization therapy devices. The programmable device lets doctors alter the site of stimulation by reprogramming it instead of doing another surgery. Acuity is the first device approved for Boston Scientific Corp. since the FDA lifted its warning letter on Monday.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ